Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Glioma × Eflornithine × Clear all

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 15 Radiotherapy 7 apatinib 4 anlotinib 3 Surgical Procedures, Operative 3 Chlorotoxin 3 Positron Emission Tomography Computed Tomography 2 Pemetrexed 2 Magnetic Resonance Spectroscopy 2 Lomustine 2 Immunotherapy, Adoptive 2 Blood Specimen Collection 2 Bevacizumab 2 Aminolevulinic Acid 2 sodium thiosulfate 1 ribociclib 1 poly ICLC 1 lonafarnib 1 etoposide phosphate 1 Vinblastine 1 Valproic Acid 1 Tranexamic Acid 1 Surveys and Questionnaires 1 Rivaroxaban 1 Radiosurgery 1 Radiation 1 Propofol 1 Polymerase Chain Reaction 1 Poly I-C 1 Metformin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02796261 2022-01-21

STELLAR

Orbus Therapeutics, Inc.

Phase 3 Unknown

Astrocytoma, Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡